These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 6970074

  • 1. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H, Uitendaal MP, van der Grint L, Leyva A, Pinedo HM.
    Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
    [Abstract] [Full Text] [Related]

  • 2. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
    Pinedo HM, Zaharko DS, Bull JM, Chabner BA.
    Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180
    [Abstract] [Full Text] [Related]

  • 3. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
    Eleff M, Franks PE, Wampler GL, Collins JM, Goldman ID.
    Cancer Treat Rep; 1985 Dec; 69(7-8):867-74. PubMed ID: 2410122
    [Abstract] [Full Text] [Related]

  • 4. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
    Koizumi S, Curt GA, Fine RL, Griffin JD, Chabner BA.
    J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
    [Abstract] [Full Text] [Related]

  • 5. Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action.
    Strømhaug A, Warren DJ, Slørdal L.
    Exp Hematol; 1995 May; 23(5):439-43. PubMed ID: 7720815
    [Abstract] [Full Text] [Related]

  • 6. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
    Samuels LL, Straw JA.
    Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
    [Abstract] [Full Text] [Related]

  • 7. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G.
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [Abstract] [Full Text] [Related]

  • 8. Effects of extracellular purines on cytotoxicity of methotrexate.
    Chong L, Ma G, Bartier WA, Tattersall MH.
    Cancer Chemother Pharmacol; 2010 May; 66(1):121-7. PubMed ID: 19784836
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate cytotoxicity: studies on its reversal by folates and nucleosides.
    Leyva A, Nederbragt H, Lankelma J, Pinedo HM.
    Cancer Treat Rep; 1981 May; 65 Suppl 1():45-50. PubMed ID: 6173122
    [Abstract] [Full Text] [Related]

  • 10. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
    Klubes P, Cerna I.
    Cancer Treat Rep; 1981 May; 65(1-2):107-14. PubMed ID: 7226161
    [Abstract] [Full Text] [Related]

  • 11. Purine modulation of methotrexate cytotoxicity in mammalian cell lines.
    Taylor IW, Slowiaczek P, Francis PR, Tattersall MH.
    Cancer Res; 1982 Dec; 42(12):5159-64. PubMed ID: 6958362
    [Abstract] [Full Text] [Related]

  • 12. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells.
    Piper AA, Nott SE, Mackinnon WB, Tattersall MH.
    Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
    Kinahan JJ, Otten M, Grindey GB.
    Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
    Rosenblatt DS, Whitehead VM, Matiaszuk NV, Pottier A, Vuchich MJ, Beaulieu D.
    Mol Pharmacol; 1982 May; 21(3):718-22. PubMed ID: 6180291
    [Abstract] [Full Text] [Related]

  • 15. Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells.
    Tsurusawa M, Niwa M, Katano N, Fujimoto T.
    Cancer Res; 1988 Aug 01; 48(15):4288-93. PubMed ID: 3390825
    [Abstract] [Full Text] [Related]

  • 16. Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum.
    Sobrero AF, Bertino JR.
    Int J Cell Cloning; 1986 Jan 01; 4(1):51-62. PubMed ID: 2936838
    [Abstract] [Full Text] [Related]

  • 17. The prevention of methotrexate toxicity by thymidine infusions in humans.
    Ensminger WD, Frei E.
    Cancer Res; 1977 Jun 01; 37(6):1857-63. PubMed ID: 870189
    [Abstract] [Full Text] [Related]

  • 18. Modulation versus rescue of antimetabolite toxicity by salvage metabolites administered by continuous infusion.
    Grindey GB, Semon JH, Pavelic ZP.
    Antibiot Chemother (1971); 1978 Jun 01; 23():295-304. PubMed ID: 306219
    [Abstract] [Full Text] [Related]

  • 19. [The metabolism of high-molecular-weight substances in cells and the effect of anticancer drugs].
    Kanamaru R, Kakuta H, Sato T, Ishioka C, Konishi Y, Wakui A, Dei T.
    Gan To Kagaku Ryoho; 1987 Mar 01; 14(3 Pt 2):837-44. PubMed ID: 3566294
    [Abstract] [Full Text] [Related]

  • 20. Rescue of thymidine cytotoxicity in L1210 ascites by elevated endogenous levels of deoxycytidine.
    Egan EM, Sargent L, Rosowsky A, Kufe DW.
    Cancer Treat Rep; 1981 Mar 01; 65(9-10):853-60. PubMed ID: 7273018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.